What does CUSIP 803607100 represent in this 13F holders report?

CUSIP 803607100 is the security identifier for SRPT - Sarepta Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held SRPT - Sarepta Therapeutics, Inc. - Common Stock in Q4 2019?

379 institutional investors reported SRPT - Sarepta Therapeutics, Inc. - Common Stock for Q4 2019. Use the holders table for investor-level position and value details.

Sarepta Therapeutics, Inc. - Common Stock (SRPT)

CUSIP: 803607100

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class: Equity / Common Stock
Shares outstanding: 105,070,763
Total 13F shares: 73,511,794
Share change: -142,290
Total reported value: $9,484,309,752
Put/Call ratio: 69%
Price per share: $129.04
Number of holders: 379
Value change: +$56,244,489
Number of buys: 186
Number of sells: 156

Quarterly Holders Quick Answers

What is CUSIP 803607100?
CUSIP 803607100 identifies SRPT - Sarepta Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2020
Previous quarter: Q3 2019

Recent filing periods for CUSIP 803607100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of SRPT - Sarepta Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	7.7%	8,062,097	$607,238,000	—	30 Sep 2019	13F
VANGUARD GROUP INC	13F	Company	6.1%	6,365,230	$479,429,000	—	30 Sep 2019	13F
BlackRock Finance, Inc.	13F	Company	4.3%	4,505,741	$339,373,000	—	30 Sep 2019	13F
SANDS CAPITAL MANAGEMENT, LLC	13F	Company	3.8%	3,952,090	$297,671,000	—	30 Sep 2019	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	3.6%	3,788,069	$285,317,000	—	30 Sep 2019	13F
JANUS HENDERSON GROUP PLC	13F	Company	2.2%	2,305,340	$173,638,000	—	30 Sep 2019	13F
FIL Ltd	13F	Company	2.1%	2,254,932	$169,841,000	—	30 Sep 2019	13F
STATE STREET CORP	13F	Company	2.1%	2,193,055	$165,181,000	—	30 Sep 2019	13F
Invesco Ltd.	13F	Company	1.7%	1,819,026	$137,010,000	—	30 Sep 2019	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	1.6%	1,724,956	$129,924,000	—	30 Sep 2019	13F
Avoro Capital Advisors LLC	13F	Company	1.6%	1,678,000	$126,387,000	—	30 Sep 2019	13F
CADIAN CAPITAL MANAGEMENT, LP	13F	Company	1.2%	1,252,500	$94,338,000	—	30 Sep 2019	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	1.2%	1,219,000	$91,815,000	—	30 Sep 2019	13F
Bank of New York Mellon Corp	13F	Company	1.1%	1,187,625	$89,452,000	—	30 Sep 2019	13F
WADDELL & REED FINANCIAL INC	13F	Company	1.1%	1,187,126	$89,414,000	—	30 Sep 2019	13F
JENNISON ASSOCIATES LLC	13F	Company	1%	1,099,693	$82,829,000	—	30 Sep 2019	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.99%	1,039,316	$78,282,000	—	30 Sep 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.98%	1,027,298	$77,376,000	—	30 Sep 2019	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	0.91%	953,332	$71,805,000	—	30 Sep 2019	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	0.9%	950,441	$71,587,000	—	30 Sep 2019	13F
Casdin Capital, LLC	13F	Company	0.84%	880,000	$66,281,600	—	30 Sep 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.8%	840,975	$63,339,000	—	30 Sep 2019	13F
ORBIMED ADVISORS LLC	13F	Company	0.8%	837,349	$63,069,000	—	30 Sep 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.72%	758,130	$57,061,000	—	30 Sep 2019	13F
Camber Capital Management LP	13F	Company	0.71%	750,000	$56,490,000	—	30 Sep 2019	13F
RTW INVESTMENTS, LP	13F	Company	0.69%	724,311	$54,555,000	—	30 Sep 2019	13F
Point72 Asset Management, L.P.	13F	Company	0.66%	696,685	$52,474,000	—	30 Sep 2019	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.65%	678,851	$51,131,000	—	30 Sep 2019	13F
FIRST TRUST ADVISORS LP	13F	Company	0.64%	669,320	$50,413,000	—	30 Sep 2019	13F
Artisan Partners Limited Partnership	13F	Company	0.61%	640,639	$48,253,000	—	30 Sep 2019	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.53%	558,639	$42,077,000	—	30 Sep 2019	13F
Boxer Capital, LLC	13F	Company	0.52%	550,000	$41,426,000	—	30 Sep 2019	13F
Erste Asset Management GmbH	13F	Company	0.52%	548,660	$41,290,223	—	30 Sep 2019	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.51%	537,574	$40,490,000	—	30 Sep 2019	13F
NORGES BANK	13F	Company	0.48%	501,123	$37,745,000	—	30 Sep 2019	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.47%	492,600	$37,104,000	—	30 Sep 2019	13F
Alyeska Investment Group, L.P.	13F	Company	0.45%	475,254	$35,796,000	—	30 Sep 2019	13F
NORTHERN TRUST CORP	13F	Company	0.41%	435,735	$32,819,000	—	30 Sep 2019	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.41%	435,300	$32,786,000	—	30 Sep 2019	13F
Sumitomo Mitsui Trust Group, Inc.	13F	Company	0.39%	405,332	$30,530,000	—	30 Sep 2019	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.37%	393,101	$29,608,367	—	30 Sep 2019	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.37%	391,933	$29,519,000	—	30 Sep 2019	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.36%	382,000	$28,772,000	—	30 Sep 2019	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.33%	348,078	$26,217,000	—	30 Sep 2019	13F
CREDIT SUISSE AG/	13F	Company	0.32%	340,630	$25,657,000	—	30 Sep 2019	13F
CARILLON TOWER ADVISERS, INC.	13F	Company	0.32%	339,743	$25,589,000	—	30 Sep 2019	13F
Rock Springs Capital Management LP	13F	Company	0.32%	337,500	$25,421,000	—	30 Sep 2019	13F
CITADEL ADVISORS LLC	13F	Company	0.32%	331,630	$24,978,000	—	30 Sep 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.31%	324,984	$24,478,000	—	30 Sep 2019	13F
WESTFIELD CAPITAL MANAGEMENT CO LP	13F	Company	0.31%	320,561	$24,145,000	—	30 Sep 2019	13F

Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock (SRPT) as of Q4 2019

As of 31 Dec 2019, Sarepta Therapeutics, Inc. - Common Stock (SRPT) was held by 379 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 73,511,794 shares. The largest 10 holders included FMR LLC, VANGUARD GROUP INC, BlackRock Inc., SANDS CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, Capital Research Global Investors, STATE STREET CORP, Invesco Ltd., and Avoro Capital Advisors LLC. This page lists 379 institutional shareholders reporting positions in this security for the Q4 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2019 vs Q3 2019 Across Filers

Q3 2019 holders

329

Q4 2019 holders

379

Holder diff

Investor	Q3 2019 Shares	Q4 2019 Shares	Share Diff	Share Chg %	Q3 2019 Value $	Q4 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.